Skip to content

Comments on "Ketamine's double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant obsessive compulsive disorder (OCD)-A case series".

Indian J Psychiatry February 23, 2026 DOI: 10.4103/indianjpsychiatry_821_25 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case report Peer reviewed
Topics Esketamine Ketamine

Abstract

Comments on "Ketamine's double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant obsessive compulsive disorder (OCD)-A case series".